New Computer Program Expedites Drug Development for Type II Diabetes
News
In a new study entitled “Computational re-engineering of Amylin sequence with reduced amyloidogenic potential”, computational scientists designed a new program that will foster the development of drugs for misfolded proteins-associated ... Read more
A Day In The Life With Type 1 Diabetes: Devin’s Experience
Type 2 Diabetes Patients at Risk of Developing Nonalcoholic Fatty Liver Disease and Advanced Fibrosis
News
In a recently published paper in the Alimentary Pharmacology and Therapeutics journal, entitled “Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE“, researchers ... Read more
New International Clinical Trial To Evaluate Allopurinol for Diabetic Nephropathy in Type 1 Diabetics
News
A new clinical trial study is currently underway at fourteen different sites across the world, including the UT Southwestern Medical Center, evaluating the use of allopurinol in the prevention of ... Read more
A Closer Look at the Side-Effects of Diabetes
Type 1 Diabetes Blog
One particular thing that diabetics have to always consider is the impact that the disease itself can have on the development of other pathologies. This is a tough reality that diabetics ... Read more
Weight Loss Surgery Better Than Standard Therapy at Controlling Type 2 Diabetes in Obese Patients
News, Type 2 Diabetes News
In a new study entitled “Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomized controlled trial,” scientists show ... Read more
Jardiance® is the First Type 2 Diabetes Medication to Significantly Reduce Risk of Cardiovascular Complications and Death
News
Type II diabetes medication Jardiance® (empagliflozin) by Boehringer Ingelheim and Eli Lilly and Company, recently became the first of its kind to demonstrate a significantly lowered risk of cardiovascular risk and death, ... Read more
Study Suggests Obese, Type 2 Diabetes Patients Should Have Priority for Obesity Surgery Over Patients Without Diabetes
News, Type 2 Diabetes News
A new study recently published in the journal The Lancet Diabetes & Endocrinology indicates that obese patients with type 2 diabetes should be prioritized over obese patients without the disease ... Read more
Sanofi Reports Promising Phase III Clinical Trial Results for Diabetes Drug Combination: Insulin Glargine Plus Lixisenatide
News, Type 2 Diabetes News
Sanofi recently announced that its Phase III clinical trial called LixiLan-L, assessing the safety and efficacy of the fixed ratio combination of insulin glargine (100 Units/mL) and lixisenatide in patients with ... Read more
Blocking Hyaluronan Pancreas Buildup Prevents Type 1 Diabetes
News
In a new study entitled “Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis” researchers at Stanford University discovered that deposits of a substance called hyaluronan to the pancreas ... Read more
DRI BioHub Enables Type 1 Diabetic To Produce Her Own Insulin
News
A type 1 diabetic patient treated in a clinical trial at The Diabetes Research Institute (DRI; a Center of Excellence at the University of Miami Miller School of Medicine) no ... Read more